Some studies examined full-length TDP-43 in CSF or blood as an ALS biomarker [40, 49, 113–117], while others focused on disease-associated TDP-43 modifications [118, 119] or pathological TDP-43 fragments [40, 49]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.